
    
      The investigators will collect residuary lung tissue after medically indicated pulmonary
      resections at the Thoracic Surgery Department of University Hospitals Leuven. More
      specifically the investigators will collect lung tissue from patients that had earlier PCR
      proven COVID-19 and/or serum anti-SARS-CoV-2 antibodies.

      Furthermore, for negative control of the methodology the investigators will also collect lung
      tissue from patients that have no signs for earlier SARS-CoV-2 infection.
    
  